{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T21:03:30Z","timestamp":1761339810432,"version":"3.37.3"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T00:00:00Z","timestamp":1520812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003558","name":"Ministry of Justice","doi-asserted-by":"crossref","award":["17SFB3028"],"award-info":[{"award-number":["17SFB3028"]}],"id":[{"id":"10.13039\/501100003558","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Philosophy and Social Science Foundation","award":["17ZXC003"],"award-info":[{"award-number":["17ZXC003"]}]},{"name":"Jiangsu Philsophy and Social Science Research Fund of Colleges and Universities","award":["2017SJB1330"],"award-info":[{"award-number":["2017SJB1330"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Eng Ethics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11948-018-0043-3","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T10:50:13Z","timestamp":1520851813000},"page":"791-811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9094-0551","authenticated-orcid":false,"given":"Li","family":"Jiang","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,3,12]]},"reference":[{"key":"43_CR1","volume-title":"Intellectual property and theories of justice","author":"D Attas","year":"2008","unstructured":"Attas, D. (2008). Lockean justifications of intellectual property. In A. Gosseries, A. Marciano, & A. Strowel (Eds.), Intellectual property and theories of justice. London: Palgrave Macmillan."},{"key":"43_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2307\/782351","volume":"3","author":"DJ Brewer","year":"1943","unstructured":"Brewer, D. J. (1943). The patent system. Yale Law Journal,\n                           3, 149\u2013157.","journal-title":"Yale Law Journal"},{"key":"43_CR3","unstructured":"Budwick, D. (2016). Editas medicine announces exclusive license to advanced CRISPR genome editing technology from Massachusetts General Hospital, GlobeNewswire, August 3, 2016. \n                    http:\/\/www.nasdaq.com\/press-release\/editas-medicine-announces-exclusive-license-to-advanced-crispr-genome-editing-technology-from-20160803-00422\n                    \n                  . Accessed Sept 1, 2016."},{"issue":"4","key":"43_CR4","first-page":"338","volume":"13","author":"DL Burk","year":"2014","unstructured":"Burk, D. L., & Lemley, M. A. (2014). Is patent law technology specific? Berkeley Technology Law Journal,\n                           13(4), 338.","journal-title":"Berkeley Technology Law Journal"},{"key":"43_CR5","volume-title":"Marxian economics","author":"G Catephores","year":"1990","unstructured":"Catephores, G. (1990). Alienation. In J. Eatwell, M. Milgate, & P. Newman (Eds.), Marxian economics. London: Palgrave Macmillan."},{"issue":"7656","key":"43_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/546015a","volume":"546","author":"D Cyranoski","year":"2017","unstructured":"Cyranoski, D. (2017). Trials of embryonic stem cells to launch in China. Nature,\n                           546(7656), 15\u201316.","journal-title":"Nature"},{"key":"43_CR7","unstructured":"Disenberg, R. S. (1989). Patents and the progress of science: Exclusive rights and experimental use. The University of Chicago Law Review (pp. 1066\u20131067, Vol. 56)."},{"key":"43_CR8","volume-title":"Elizabethan monopolies: The history of the company of mineral and battery works from 1565 to 1604","author":"MB Donald","year":"1961","unstructured":"Donald, M. B. (1961). Elizabethan monopolies: The history of the company of mineral and battery works from 1565 to 1604. Edinburgh: Oliver & Boyd."},{"issue":"2","key":"43_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/187221507780887036","volume":"1","author":"AH Ebhardt","year":"2007","unstructured":"Ebhardt, A. H. (2007). RNA interference (RNAi) patents and human health related applications of RNAi. Recent Patents on DNA & Gene Sequences,\n                           1(2), 128\u2013133.","journal-title":"Recent Patents on DNA & Gene Sequences"},{"key":"43_CR10","unstructured":"Editasmedicine.com. (2017). \n                    http:\/\/ir.editasmedicine.com\/phoenix.zhtml?c=254265&p=irol-irhome\n                    \n                  . Accessed Sept 1, 2017."},{"issue":"2","key":"43_CR11","first-page":"1","volume":"25","author":"DE Ervin","year":"2010","unstructured":"Ervin, D. E., Nag, S., Yang, H., & Buccola, S. T. (2010). What drives academic bioscientists: Money or values? Choices,\n                           25(2), 1\u201316.","journal-title":"Choices"},{"key":"43_CR12","volume-title":"Intellectual property management in health and agricultural innovation: A handbook of best practices","author":"PM Feldman","year":"2007","unstructured":"Feldman, P. M., Colalanni, A., & Liu, C. K. (2007). Lessons from the commercialisation of the Cohen-Boyer patents: The standard university licensing program. In A. Krattiger, R. T. Mahoney, L. Nelsen, et al. (Eds.), Intellectual property management in health and agricultural innovation: A handbook of best practices. Oxford: MIHR."},{"issue":"8","key":"43_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.respol.2010.05.014","volume":"39","author":"R Fini","year":"2010","unstructured":"Fini, R., Lacetera, N., & Shane, S. (2010). Inside or outside the IP system? Business creation in academia. Research Policy,\n                           39(8), 1060\u20131069.","journal-title":"Research Policy"},{"issue":"4","key":"43_CR14","first-page":"1441","volume":"104","author":"JC Fromer","year":"2010","unstructured":"Fromer, J. C. (2010). A psychology of intellectual property. Northwestern University Law Review,\n                           104(4), 1441\u20131509.","journal-title":"Northwestern University Law Review"},{"key":"43_CR15","unstructured":"Genengnews.com. (2017). Editas licenses CRISPR\/Cas9, TALENs from four institutions, GEN news highlights, December 1, 2014. \n                    http:\/\/www.genengnews.com\/gen-news-highlights\/editas-licenses-crispr-cas9-talens-from-four-institutions\/81250650\/\n                    \n                  . Accessed Sept 1, 2017."},{"key":"43_CR16","unstructured":"Genewatch.org. (2018). Patenting genes-stifling research and jeopardising healthcare, Gene Watch UK, April 1, 2001. \n                    http:\/\/www.genewatch.org\/uploads\/f03c6d66a9b354535738483c1c3d49e4\/Patenting_Genes_A4_Version.pdf\n                    \n                  . Accessed Feb 23, 2018."},{"key":"43_CR17","unstructured":"Genome.gov. (2018). Reaffirmation and extension of NHGRI rapid data release policies: Large-scale sequencing and other community research projects. \n                    https:\/\/www.genome.gov\/10506537\/\n                    \n                  . Accessed Feb 26, 2018."},{"issue":"7","key":"43_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/GIM.0b013e3181d72661","volume":"12","author":"RE Gold","year":"2010","unstructured":"Gold, R. E., & Carbone, J. (2010). Myriad genetics: In the eye of the policy storm. Genetics in Medicine Official Journal of the American College of Medical Genetics,\n                           12(7), 39\u201370.","journal-title":"Genetics in Medicine Official Journal of the American College of Medical Genetics"},{"issue":"1","key":"43_CR19","first-page":"1","volume":"7","author":"RE Gold","year":"2009","unstructured":"Gold, R. E., Kaplan, W., Orbinski, J., Logan, S. H., & Marandi, S. N. (2009). Are patents impeding medical care and innovation? PloS Medicine,\n                           7(1), 1\u20135.","journal-title":"PloS Medicine"},{"issue":"1","key":"43_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2307\/1073310","volume":"79","author":"MF Grady","year":"1992","unstructured":"Grady, M. F., & Alexander, J. I. (1992). Patent law and rent dissipation. Virginia Law Review,\n                           79(1), 305\u2013350.","journal-title":"Virginia Law Review"},{"key":"43_CR21","doi-asserted-by":"crossref","unstructured":"Graham v John Deere Co. 383 U.S. 1, 5-6, 148 U.S.P.Q. (BNA) 459,462 (1996).","DOI":"10.1038\/383459a0"},{"issue":"1","key":"43_CR22","first-page":"142","volume":"25","author":"JL Greenbaum","year":"2008","unstructured":"Greenbaum, J. L. (2008). TRIPS and Public Health: Solutions for ensuring global access to essential AIDS medication in the wake of Paragraph 6 waiver. Journal of Contemporary Health Law and Policy,\n                           25(1), 142\u2013165.","journal-title":"Journal of Contemporary Health Law and Policy"},{"issue":"1","key":"43_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nbt0116-13","volume":"34","author":"D Gruchkin","year":"2016","unstructured":"Gruchkin, D. (2016). DuPont in CRISPR-Cas patent land grab. Nature Biotechnology,\n                           34(1), 13.","journal-title":"Nature Biotechnology"},{"key":"43_CR24","first-page":"359","volume":"38","author":"WW Guan","year":"2008","unstructured":"Guan, W. W. (2008). The poverty of intellectual property philosophy. Hong Kong Law Journal,\n                           38, 359\u2013397.","journal-title":"Hong Kong Law Journal"},{"issue":"3","key":"43_CR25","first-page":"166","volume":"30","author":"M Guilo","year":"1948","unstructured":"Guilo, M. (1948). Venetian patents. Journal of Patent Office Society,\n                           30(3), 166\u2013224.","journal-title":"Journal of Patent Office Society"},{"key":"43_CR26","volume-title":"How like a leaf: An interview with Thyrza Nichols Goodeve","author":"DJ Haraway","year":"2000","unstructured":"Haraway, D. J. (2000). How like a leaf: An interview with Thyrza Nichols Goodeve. New York: Routledge."},{"issue":"3","key":"43_CR27","first-page":"243","volume":"162","author":"G Hardin","year":"1968","unstructured":"Hardin, G. (1968). The tragedy of the commons. Science,\n                           162(3), 243\u2013253.","journal-title":"Science"},{"key":"43_CR28","first-page":"525","volume":"1","author":"RH Harn","year":"2014","unstructured":"Harn, R. H. (2014). Keeping the gates open for human embryonic stem cell research. Cardozo Public Law, Policy & Ethics Journal,\n                           1, 525\u2013558.","journal-title":"Cardozo Public Law, Policy & Ethics Journal"},{"key":"43_CR29","volume-title":"John Locke\u2019s two treatises of government","author":"EJ Harpham","year":"1992","unstructured":"Harpham, E. J. (1992). John Locke\u2019s two treatises of government. Lawrence: University of Kansas Press."},{"issue":"5364","key":"43_CR30","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1126\/science.280.5364.698","volume":"280","author":"MA Heller","year":"1998","unstructured":"Heller, M. A., & Eisenberg, R. S. (1998). Can patents deter innovation? The anticommons in biomedical research. Science,\n                           280(5364), 698\u2013701.","journal-title":"Science"},{"issue":"11","key":"43_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1517\/13543776.18.11.1289","volume":"18","author":"SL Highlander","year":"2008","unstructured":"Highlander, S. L., & Wohlers, T. M. (2008). Patent strategies for therapeutic RNAi. Expert Opinion on Therapeutic Patents,\n                           18(11), 1289\u20131298.","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"43_CR32","unstructured":"Hiltzik, M. (2014). Can scientists patent life? The question returns to the Supreme Court, Los Angeles Times, October 31, 2014. \n                    http:\/\/www.latimes.com\/business\/hiltzik\/la-fi-mh-can-scientists-patent-20141031-column.html\n                    \n                  . Accessed Feb 24, 2018."},{"key":"43_CR33","unstructured":"HinxtonGroup.org. (2010). Statement on policies and practicesgoverning data and materials sharing and intellectual property instem cell science. \n                    http:\/\/www.hinxtongroup.org\/Consensus_HG10_FINAL.pdf\n                    \n                  . Accessed Nov 28, 2017. Accessed Feb 23, 2018."},{"key":"43_CR34","first-page":"253","volume":"50","author":"ME Horn","year":"2002","unstructured":"Horn, M. E. (2002). DNA patenting and access to healthcare: Achieving the balance among competing interests. Cleveland State Law Review,\n                           50, 253\u2013282.","journal-title":"Cleveland State Law Review"},{"key":"43_CR35","first-page":"175","volume-title":"Who owns life?","author":"RL Hotz","year":"2002","unstructured":"Hotz, R. L. (2002). Falling from grace: Science and the pursuit of profit. In D. Magnus, A. Caplan, & G. McGee (Eds.), Who owns life? (pp. 175\u2013195). Amherst: Prometheus Books."},{"key":"43_CR36","first-page":"167","volume":"2","author":"H Johnson","year":"2005","unstructured":"Johnson, H. (2005). Strategies to balance patent law and low cost access to medicines. The Brown Journal of World Affairs,\n                           2, 167\u2013175.","journal-title":"The Brown Journal of World Affairs"},{"issue":"2","key":"43_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14636778.2014.914849","volume":"33","author":"Y Joly","year":"2014","unstructured":"Joly, Y., & Tonin, P. N. (2014a). Social, ethical and legal considerations raised by the discovery and patenting of the BRCA1 and BRCA2 gene. New Genetics and Society,\n                           33(2), 167\u2013180.","journal-title":"New Genetics and Society"},{"issue":"2","key":"43_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14636778.2014.914849","volume":"33","author":"Y Joly","year":"2014","unstructured":"Joly, Y., & Tonin, P. N. (2014b). Social, ethical and legal considerations raised by the discovery and patenting of the BRCA1 and BCA2 genes. New Genetics and Society,\n                           33(2), 167\u2013180.","journal-title":"New Genetics and Society"},{"key":"43_CR39","unstructured":"Kica, E., & Groenendijk, N. (2009). The governance of European intellectual property rights: Toward a differentiated community approach. \n                    https:\/\/ris.utwente.nl\/ws\/portalfiles\/portal\/6170350\n                    \n                  . Accessed Jan 25, 2018."},{"issue":"1","key":"43_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/13511610.2011.571405","volume":"24","author":"E Kica","year":"2011","unstructured":"Kica, E., & Groenendijk, N. (2011). The European patent system: Dealing with emerging technologies. The European Journal of Social Science Research,\n                           24(1), 85\u2013105.","journal-title":"The European Journal of Social Science Research"},{"key":"43_CR41","unstructured":"Killick, J., Schulz, A., & Dawes, A. (2006). The special regime of intellectual property for the pharmaceutical industry. The White & Case Publication. \n                    http:\/\/jp.whitecase.com\/files\/Publication\/87735062-ad5f-4fe6-9056-04280420e45d\/Presentation\/PublicationAttachment\/74d11d62-2d69-4207-b87e-0d30877f5111\/article_Special_Regime_of_Intellectual_Property.pdf\n                    \n                  . Accessed Feb 23, 2018."},{"issue":"2","key":"43_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/466903","volume":"20","author":"EW Kitch","year":"1977","unstructured":"Kitch, E. W. (1977). The nature of function of the patent system. The Journal of Law and Economics,\n                           20(2), 265\u2013290.","journal-title":"The Journal of Law and Economics"},{"issue":"6","key":"43_CR43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jmoldx.2013.09.002","volume":"15","author":"RD Klein","year":"2013","unstructured":"Klein, R. D. (2013). AMP v Myriad: The supreme court gives a win to personalised medicine. The Journal of Molecular Diagnostics,\n                           15(6), 731\u2013732.","journal-title":"The Journal of Molecular Diagnostics"},{"issue":"10","key":"43_CR44","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.respol.2011.09.002","volume":"40","author":"A Lam","year":"2011","unstructured":"Lam, A. (2011). What motivates academic scientists to engage in research commercialisation: \u2018Gold\u2019, \u2018Ribbon\u2019 or \u2018Puzzle\u2019. Research Policy,\n                           40(10), 1354\u20131368.","journal-title":"Research Policy"},{"key":"43_CR45","first-page":"1077","volume":"5","author":"P Lee","year":"2012","unstructured":"Lee, P. (2012). The Supreme Court\u2019s Myriad effects on scientific research: Definitional fluidity and the legal construction of nature. UC Irvine Law Review,\n                           5, 1077\u20131114.","journal-title":"UC Irvine Law Review"},{"issue":"1","key":"43_CR46","first-page":"129","volume":"71","author":"MA Lemley","year":"2004","unstructured":"Lemley, M. A. (2004a). Ex ante versus ex post justifications for intellectual property. The University of Chicago Law Review,\n                           71(1), 129\u2013149.","journal-title":"The University of Chicago Law Review"},{"issue":"4","key":"43_CR47","first-page":"1031","volume":"83","author":"MA Lemley","year":"2004","unstructured":"Lemley, M. A. (2004b). Property, intellectual property, and free riding. Texas Law Review,\n                           83(4), 1031\u20131075.","journal-title":"Texas Law Review"},{"issue":"20","key":"43_CR48","first-page":"545","volume":"149","author":"AN Littman","year":"1996","unstructured":"Littman, A. N. (1996). Restoring the balance of our patent system. IDEA The Journal of Law and Technology,\n                           149(20), 545\u2013570.","journal-title":"IDEA The Journal of Law and Technology"},{"key":"43_CR49","unstructured":"Loring, J. (2007). A patent challenge for human embryonic stem cell research. Nature reports stem cells. November 8, 2007. \n                    http:\/\/www.nature.com\/stemcells\/2007\/0711\/071108\/full\/stemcells.2007.113.html\n                    \n                  . Accessed Feb 23, 2018."},{"issue":"1","key":"43_CR50","first-page":"1","volume":"10","author":"F Machlup","year":"1950","unstructured":"Machlup, F., & Penrose, E. (1950). The patent controversy in the nineteenth century. Cambridge University Press,\n                           10(1), 1\u201329.","journal-title":"Cambridge University Press"},{"issue":"3","key":"43_CR51","first-page":"178","volume":"52","author":"TF Maffei","year":"1970","unstructured":"Maffei, T. F. (1970). The Patent misuse doctrine: A balance of patent rights and the public interest. Journal of patent office and society,\n                           52(3), 178\u2013202.","journal-title":"Journal of patent office and society"},{"issue":"3","key":"43_CR52","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10961-007-9031-5","volume":"33","author":"A Martinelli","year":"2008","unstructured":"Martinelli, A., Meyer, M., & Tunzehnann, N. V. (2008). Becoming an entrepreneurial university? A case study of knowledge exchange relationships and faculty attitudes in a medium-sized, research oriented university. Journal of Technology Transfer,\n                           33(3), 259\u2013283.","journal-title":"Journal of Technology Transfer"},{"issue":"2","key":"43_CR53","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2217\/rme.13.93","volume":"9","author":"KRW Matthews","year":"2014","unstructured":"Matthews, K. R. W., & Cuchiara, M. L. (2014). Gene patents, patenting life and the impact of court rulings on US stem cell patents and research. Regenerative Medicine,\n                           9(2), 191\u2013200.","journal-title":"Regenerative Medicine"},{"key":"43_CR54","unstructured":"McDowell, T. (2012). Carnegie Institution and UMass Medical School granted broad US Patent related to RNA interference, EurekAlert, October 16, 2012. \n                    https:\/\/www.eurekalert.org\/pub_releases\/2012-10\/ci-cia101612.php\n                    \n                  . Accessed Oct 10, 2017."},{"issue":"1","key":"43_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2307\/1073312","volume":"78","author":"RP Merges","year":"1992","unstructured":"Merges, R. P. (1992). Rent control in the patent district: Observations on the Grady\u2013Alexander thesis. Virginia Law Review,\n                           78(1), 359\u2013381.","journal-title":"Virginia Law Review"},{"issue":"6","key":"43_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2307\/2089193","volume":"22","author":"RK Merton","year":"1957","unstructured":"Merton, R. K. (1957). Priorities in scientific discovery: A chapter in the sociology of science. American Sociological Review,\n                           22(6), 635\u2013659.","journal-title":"American Sociological Review"},{"key":"43_CR57","volume-title":"Intellectual property rights and research tools in molecular biology","author":"National Research Council","year":"1997","unstructured":"National Research Council. (1997). Intellectual property rights and research tools in molecular biology. Washington, DC: National Academies Press."},{"key":"43_CR58","unstructured":"Nicol, D., & Nielsen, J. (2003). Patents and medical biotechnology: An empirical analysis of issues facing the Australian industry (Occasional paper 64\u201371, Vol. 6). University of Tasmania Centre for Law and Genetics."},{"key":"43_CR59","unstructured":"Nihcm.org. (2018). Changing patterns of pharmaceutical innovation. A research report by the National Institute for Health Care Management Research and Educational Foundation. \n                    https:\/\/www.nihcm.org\/pdf\/innovations.pdf\n                    \n                  . Accessed Feb 24, 2018."},{"issue":"11","key":"43_CR60","first-page":"815","volume":"82","author":"MA Oliveira","year":"2004","unstructured":"Oliveira, M. A., Bermudez, J. A. Z., Chaves, G. C., & Velasquez, G. (2004). Has the Implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health? Bulletin of the World Health Organization,\n                           82(11), 815\u2013821.","journal-title":"Bulletin of the World Health Organization"},{"key":"43_CR61","unstructured":"Page, M. L. (2017). First results of CRISPR gene editing of normal embryos released, New scientist. \n                    https:\/\/www.newscientist.com\/article\/2123973-first-results-of-crispr-gene-editing-of-normal-embryos-released\/\n                    \n                  . Accessed June 12, 2017."},{"key":"43_CR62","unstructured":"Parthasarathy, S. (2016). CRISPR dispute raises bigger patent issues that we\u2019re not talking about, PHYS.ORG. \n                    http:\/\/phys.org\/news\/2016-04-crispr-dispute-bigger-patent-issues.html\n                    \n                  . Accessed July 29, 2016."},{"issue":"1","key":"43_CR63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1353\/hrq.2013.0015","volume":"35","author":"A Plomer","year":"2013","unstructured":"Plomer, A. (2013). The human rights paradox: Intellectual property rights and rights of access to science. Human Rights Quarterly,\n                           35(1), 143\u2013175.","journal-title":"Human Rights Quarterly"},{"key":"43_CR64","doi-asserted-by":"publisher","DOI":"10.4337\/9781783475933","volume-title":"Patents, human rights and access to science","author":"A Plomer","year":"2015","unstructured":"Plomer, A. (2015). Patents, human rights and access to science. London: Edward Elgar Publishing Ltd."},{"issue":"1","key":"43_CR65","first-page":"69","volume":"15","author":"J Potenza","year":"2005","unstructured":"Potenza, J., Bennett, P., & Roth, C. (2005). Patent misuse-the critical balance, a patent lawyer\u2019s view. The Federal Circuit Bar Journal,\n                           15(1), 69\u2013100.","journal-title":"The Federal Circuit Bar Journal"},{"issue":"3","key":"43_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nbt0307-273","volume":"25","author":"C Schmidt","year":"2007","unstructured":"Schmidt, C. (2007). Negotiating the RNAi patent thicket. Nature Biotechnology,\n                           25(3), 273\u2013275.","journal-title":"Nature Biotechnology"},{"issue":"2","key":"43_CR67","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF00135387","volume":"15","author":"R Schmitt","year":"1996","unstructured":"Schmitt, R. (1996). Marx\u2019s concept of alienation. Topoi,\n                           15(2), 163\u2013176.","journal-title":"Topoi"},{"key":"43_CR68","unstructured":"Seabrook, J. (1993). The flash of genius. The New Yorker, January 11, 1993. \n                    http:\/\/www.newyorker.com\/magazine\/1993\/01\/11\/the-flash-of-genius\n                    \n                  . Accessed Feb 23, 2018."},{"key":"43_CR69","unstructured":"Servick, K. (2014). US Federal Court dismisses challenge to stem cell patent, science, June 10, 2014. \n                    http:\/\/www.sciencemag.org\/news\/2014\/06\/us-federal-court-dismisses-challenge-stem-cell-patent\n                    \n                  . Accessed Feb 24, 2018."},{"key":"43_CR70","unstructured":"Sharma, R., & Kashyap, K. A. (2010). Trips & Public Health: With special reference to Doha declaration & Indian patents law, in law, society and biotechnology interface: Emerging issues in North Western Region\u2019 National Seminar, January 29\u201330, 2010. \n                    https:\/\/papers.ssrn.com\/sol3\/cf_dev\/AbsByAuth.cfm?per_id=714709\n                    \n                  . Accessed Feb 23, 2018."},{"issue":"7598","key":"43_CR71","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/532172a","volume":"532","author":"JS Sherkow","year":"2016","unstructured":"Sherkow, J. S. (2016). Pursuit of profit poisons collaboration. Nature,\n                           532(7598), 172\u2013173.","journal-title":"Nature"},{"issue":"2","key":"43_CR72","first-page":"361","volume":"55","author":"M Skladany","year":"2008","unstructured":"Skladany, M. (2008). Alienation by copyright: Abolishing copyright to spur individual creativity. Journal of Copyright Society of USA,\n                           55(2), 361\u2013392.","journal-title":"Journal of Copyright Society of USA"},{"key":"43_CR73","first-page":"141","volume":"87","author":"AR Sommer","year":"2005","unstructured":"Sommer, A. R. (2005). Trouble on the commons: A Lockean justification for patent law harmonization. Journal of Patent and Trademark Office Society,\n                           87, 141\u2013170.","journal-title":"Journal of Patent and Trademark Office Society"},{"key":"43_CR74","unstructured":"Summerfield, M. (2016). CRISPR patent dispute-is it just too big to settle, Patentology, April 17, 2016. \n                    http:\/\/blog.patentology.com.au\/2016\/04\/crispr-patent-dispute-is-it-just-too.html\n                    \n                  . Accessed Feb 20, 2018."},{"issue":"5","key":"43_CR75","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/jwip.12087","volume":"20","author":"MW Tvedt","year":"2017","unstructured":"Tvedt, M. W., & Forsberg, E. M. (2017). The room for ethical considerations in patent law applied to biotechnology. Journal of World Intellectual Property,\n                           20(5), 160\u2013177.","journal-title":"Journal of World Intellectual Property"},{"key":"43_CR76","unstructured":"US Patent 5,843,780, US patent 6,200,806 and US patent 7, 029,913."},{"key":"43_CR77","volume-title":"Patents in the knowledge-based economy","author":"JP Walsh","year":"2003","unstructured":"Walsh, J. P., Arora, A., & Cohen, W. M. (2003). Effects of research tool patents and licensing on biomedical innovation. In M. W. Cohen & S. A. Merrill (Eds.), Patents in the knowledge-based economy. Washington, DC: National Academic Press."},{"issue":"5743","key":"43_CR78","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1126\/science.1115813","volume":"309","author":"JP Walsh","year":"2005","unstructured":"Walsh, J. P., Cho, C., & Cohen, W. M. (2005). View from the bench: Patents and material transfers. Science,\n                           309(5743), 2002\u20132003.","journal-title":"Science"},{"key":"43_CR79","first-page":"665","volume":"78","author":"EC Walterscheild","year":"1996","unstructured":"Walterscheild, E. C. (1996). The early evolution of the US Patent Law: Antecedents. Journal of Patent and Trademark Office Society,\n                           78, 665.","journal-title":"Journal of Patent and Trademark Office Society"},{"issue":"11","key":"43_CR80","first-page":"789","volume":"15","author":"JJ Ward","year":"1953","unstructured":"Ward, J. J. (1953). The United States patent system. Journal of the Patent Office Society,\n                           15(11), 789\u2013809.","journal-title":"Journal of the Patent Office Society"},{"key":"43_CR81","doi-asserted-by":"publisher","DOI":"10.1057\/9780230233997","volume-title":"Karl Marx on technology and alienation","author":"AE Wendling","year":"2009","unstructured":"Wendling, A. E. (2009). Karl Marx on technology and alienation. London: Palgrave Macmillan."},{"key":"43_CR82","unstructured":"Whitehouse.gov. (2018). Article 1, Section\u00a08, CI. 8 of the US Constitution, \n                    https:\/\/www.whitehouse.gov\/about-the-white-house\/the-constitution\/\n                    \n                  . Accessed Feb 28, 2018."},{"key":"43_CR83","unstructured":"Wipo.int. (2018). The Norwegian patent act, as amended by Royal Decree of December 14, 2007, Revised in force from January 1, 2015. \n                    http:\/\/www.wipo.int\/wipolex\/en\/text.jsp?file_id=225706\n                    \n                  . Accessed Feb 25, 2018."},{"key":"43_CR84","unstructured":"Wto.org. (2018). The world trade organization (WTO) agreement on trade related intellectual property rights. \n                    https:\/\/www.wto.org\/english\/tratop_e\/trips_e\/intel2_e.htm\n                    \n                  , Accessed Feb 24, 2018."}],"container-title":["Science and Engineering Ethics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11948-018-0043-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11948-018-0043-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11948-018-0043-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T21:04:32Z","timestamp":1567890272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11948-018-0043-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,12]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1007\/s11948-018-0043-3","relation":{},"ISSN":["1353-3452","1471-5546"],"issn-type":[{"type":"print","value":"1353-3452"},{"type":"electronic","value":"1471-5546"}],"subject":[],"published":{"date-parts":[[2018,3,12]]},"assertion":[{"value":"13 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}